Nicoll
AJ
et al. Beneficial response to
mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels. Aliment Pharmacol Ther. 2019 May;49(10):1314–22.
[PubMed: 30972807]